Qulipta and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Qulipta (atogepant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zofran, and have Migraine.

The phase IV clinical study analyzes which people have Abdominal pain when taking Qulipta. It is created by eHealthMe based on reports of 3,582 people who have side effects when taking Qulipta from the FDA, and is updated regularly.

What is Qulipta?

Qulipta has active ingredients of atogepant. eHealthMe is studying from 3,605 Qulipta users. Check the latest studies of Qulipta.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,237 drugs and 5,742 conditions by eHealthMe. Check the latest studies of Abdominal pain.



On Apr, 17, 2026

3,582 people reported to have side effects when taking Qulipta.
Among them, 25 people (0.7%) have Abdominal pain.

Could Qulipta cause Abdominal pain?

Among these 25 people:

How long have people been on Qulipta when they have Abdominal pain? *

  • < 1 month: 20 %
  • 1 - 6 months: 80 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Abdominal pain when taking Qulipta? *

  • female: 90.48 %
  • male: 9.52 %

What is the age of people who have Abdominal pain when taking Qulipta? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.14 %
  • 40-49: 21.43 %
  • 50-59: 35.71 %
  • 60+: 35.71 %

What are other drugs people take besides Qulipta? *

  1. Zofran: 3 people, 12.00%
  2. Magnesium Oxide: 2 people, 8.00%
  3. Hydrochlorothiazide: 2 people, 8.00%
  4. Adderall: 2 people, 8.00%
  5. Magnesium: 2 people, 8.00%
  6. Losartan Potassium: 2 people, 8.00%
  7. Vitamin B2: 2 people, 8.00%
  8. Promethazine: 2 people, 8.00%
  9. Gabapentin: 2 people, 8.00%
  10. Lidocaine: 2 people, 8.00%

What are other side effects people have besides Abdominal pain? *

  1. Nausea (feeling of having an urge to vomit): 11 people, 44.00%
  2. Constipation: 8 people, 32.00%
  3. Headache (pain in head): 7 people, 28.00%
  4. Migraine (headache): 6 people, 24.00%
  5. Nausea And Vomiting: 3 people, 12.00%
  6. Drug Ineffective: 3 people, 12.00%
  7. Impaired Gastric Emptying: 3 people, 12.00%
  8. Pain In Extremity: 2 people, 8.00%
  9. Pain: 2 people, 8.00%
  10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 8.00%

What are the existing conditions these people have? *

  1. Migraine (headache): 15 people, 60.00%
  2. Muscle Spasms (muscle contraction): 2 people, 8.00%
  3. Stress And Anxiety: 2 people, 8.00%
  4. Headache (pain in head): 2 people, 8.00%
  5. Pain: 2 people, 8.00%
  6. Back Pain: 1 person, 4.00%
  7. Constipation: 1 person, 4.00%
  8. Depression: 1 person, 4.00%
  9. High Blood Pressure: 1 person, 4.00%
  10. Hot Flush (sudden feelings of heat): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Qulipta and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qulipta:

Abdominal pain treatments and more:

How severe was Abdominal pain and when was it recovered:

Expand to all the drugs that have ingredients of atogepant:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Qulipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Browse all the conditions that are associated with Abdominal pain:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atogepant (the active ingredients of Qulipta) and Qulipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: